LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $125,252,000 | -21.5% | 894,207 | -4.3% | 0.01% | -8.3% |
| Q3 2018 | $159,592,000 | +4.9% | 934,244 | +6.5% | 0.01% | -7.7% |
| Q2 2018 | $152,167,000 | +29.8% | 877,166 | -13.6% | 0.01% | +30.0% |
| Q1 2018 | $117,187,000 | +18.0% | 1,015,733 | -13.9% | 0.01% | +25.0% |
| Q4 2017 | $99,274,000 | +12.4% | 1,179,322 | +23.0% | 0.01% | 0.0% |
| Q3 2017 | $88,354,000 | +104.2% | 959,132 | +77.8% | 0.01% | +100.0% |
| Q2 2017 | $43,264,000 | +87.9% | 539,555 | -1.4% | 0.00% | +100.0% |
| Q1 2017 | $23,019,000 | +234.5% | 547,017 | +155.2% | 0.00% | +100.0% |
| Q4 2016 | $6,882,000 | +25.2% | 214,321 | +2.1% | 0.00% | 0.0% |
| Q3 2016 | $5,497,000 | +18.0% | 209,961 | +4.4% | 0.00% | 0.0% |
| Q2 2016 | $4,658,000 | +28.0% | 201,021 | +51.1% | 0.00% | – |
| Q1 2016 | $3,638,000 | +3.1% | 133,074 | +7.4% | 0.00% | – |
| Q4 2015 | $3,530,000 | +285.4% | 123,932 | +136.0% | 0.00% | – |
| Q3 2015 | $916,000 | +3.6% | 52,505 | +7.2% | 0.00% | – |
| Q2 2015 | $884,000 | +104.2% | 49,000 | +40.4% | 0.00% | – |
| Q1 2015 | $433,000 | +9.6% | 34,900 | +3.3% | 0.00% | – |
| Q4 2014 | $395,000 | +74.8% | 33,800 | +97.7% | 0.00% | – |
| Q3 2014 | $226,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|